| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| S0109 |
Methadone, oral, 5 mg |
72,891 |
14,911 |
$15.29M |
| H0020 |
Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) |
84,982 |
16,436 |
$1.62M |
| H0016 |
Alcohol and/or drug services; medical/somatic (medical intervention in ambulatory setting) |
14,389 |
8,331 |
$1.22M |
| H0004 |
Behavioral health counseling and therapy, per 15 minutes |
20,321 |
12,812 |
$930K |
| H0048 |
Alcohol and/or other drug testing: collection and handling only, specimens other than blood |
22,444 |
14,395 |
$313K |
| H0001 |
Alcohol and/or drug assessment |
1,541 |
1,445 |
$257K |
| J0572 |
Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine |
2,631 |
498 |
$186K |
| H0005 |
Alcohol and/or drug services; group counseling by a clinician |
3,467 |
1,393 |
$167K |
| H0006 |
Alcohol and/or drug services; case management |
5,731 |
3,157 |
$107K |
| H0032 |
Mental health service plan development by non-physician |
761 |
730 |
$90K |
| H0033 |
Oral medication administration, direct observation |
5,242 |
973 |
$85K |
| 80305 |
|
8,034 |
5,507 |
$67K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,401 |
1,476 |
$45K |
| J3490 |
Unclassified drugs |
1,113 |
65 |
$42K |
| 93000 |
|
1,346 |
1,281 |
$15K |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
339 |
328 |
$14K |
| 86580 |
|
918 |
889 |
$6K |
| 81025 |
|
564 |
321 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
69 |
68 |
$3K |
| 84702 |
|
223 |
157 |
$1K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
50 |
49 |
$1K |
| 98966 |
|
62 |
46 |
$656.97 |
| G1028 |
Take-home supply of nasal naloxone; 2-pack of 8mg per 0.1 ml nasal spray (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure |
28 |
25 |
$0.00 |